BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 37692522)

  • 1. Crosstalk between glioblastoma and tumor microenvironment drives proneural-mesenchymal transition through ligand-receptor interactions.
    Lai Y; Lu X; Liao Y; Ouyang P; Wang H; Zhang X; Huang G; Qi S; Li Y
    Genes Dis; 2024 Mar; 11(2):874-889. PubMed ID: 37692522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proneural-Mesenchymal Transition: Phenotypic Plasticity to Acquire Multitherapy Resistance in Glioblastoma.
    Fedele M; Cerchia L; Pegoraro S; Sgarra R; Manfioletti G
    Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31167470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current Insights into Mesenchymal Signatures in Glioblastoma.
    Matsumoto Y; Ichikawa T; Kurozumi K; Date I
    Acta Med Okayama; 2022 Oct; 76(5):489-502. PubMed ID: 36352795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Voxel-Based Radiographic Analysis Reveals the Biological Character of Proneural-Mesenchymal Transition in Glioblastoma.
    Qi T; Meng X; Wang Z; Wang X; Sun N; Ming J; Ren L; Jiang C; Cai J
    Front Oncol; 2021; 11():595259. PubMed ID: 33816228
    [No Abstract]   [Full Text] [Related]  

  • 5. 4-Hydroxy-7-oxo-5-heptenoic acid lactone is a potent inducer of brain cancer cell invasiveness that may contribute to the failure of anti-angiogenic therapies.
    Tomko N; Kluever M; Wu C; Zhu J; Wang Y; Salomon RG
    Free Radic Biol Med; 2020 Jan; 146():234-256. PubMed ID: 31715381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration analysis of single-cell and spatial transcriptomics reveal the cellular heterogeneity landscape in glioblastoma and establish a polygenic risk model.
    Liu Y; Wu Z; Feng Y; Gao J; Wang B; Lian C; Diao B
    Front Oncol; 2023; 13():1109037. PubMed ID: 37397378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDIA3P1 promotes Temozolomide resistance in glioblastoma by inhibiting C/EBPβ degradation to facilitate proneural-to-mesenchymal transition.
    Gao Z; Xu J; Fan Y; Qi Y; Wang S; Zhao S; Guo X; Xue H; Deng L; Zhao R; Sun C; Zhang P; Li G
    J Exp Clin Cancer Res; 2022 Jul; 41(1):223. PubMed ID: 35836243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ME2 Promotes Proneural-Mesenchymal Transition and Lipogenesis in Glioblastoma.
    Yang M; Chen X; Zhang J; Xiong E; Wang Q; Fang W; Li L; Fei F; Gong A
    Front Oncol; 2021; 11():715593. PubMed ID: 34381734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mesenchymal stem cell-glioblastoma interactions mediated via kinin receptors unveiled by cytometry.
    Pillat MM; Oliveira-Giacomelli Á; das Neves Oliveira M; Andrejew R; Turrini N; Baranova J; Lah Turnšek T; Ulrich H
    Cytometry A; 2021 Feb; 99(2):152-163. PubMed ID: 33438373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RBPJ contributes to the malignancy of glioblastoma and induction of proneural-mesenchymal transition via IL-6-STAT3 pathway.
    Zhang G; Tanaka S; Jiapaer S; Sabit H; Tamai S; Kinoshita M; Nakada M
    Cancer Sci; 2020 Nov; 111(11):4166-4176. PubMed ID: 32885530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. USP10 deubiquitinates RUNX1 and promotes proneural-to-mesenchymal transition in glioblastoma.
    Qiu W; Xiao Z; Yang Y; Jiang L; Song S; Qi X; Chen Y; Yang H; Liu J; Chu L
    Cell Death Dis; 2023 Mar; 14(3):207. PubMed ID: 36949071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene signatures of quiescent glioblastoma cells reveal mesenchymal shift and interactions with niche microenvironment.
    Tejero R; Huang Y; Katsyv I; Kluge M; Lin JY; Tome-Garcia J; Daviaud N; Wang Y; Zhang B; Tsankova NM; Friedel CC; Zou H; Friedel RH
    EBioMedicine; 2019 Apr; 42():252-269. PubMed ID: 30952620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An update on the molecular biology of glioblastoma, with clinical implications and progress in its treatment.
    Verdugo E; Puerto I; Medina MÁ
    Cancer Commun (Lond); 2022 Nov; 42(11):1083-1111. PubMed ID: 36129048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner.
    Wu J; Shen S; Liu T; Ren X; Zhu C; Liang Q; Cui X; Chen L; Cheng P; Cheng W; Wu A
    Oncogene; 2022 May; 41(21):3024-3036. PubMed ID: 35459783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CXCL12 modulation of CXCR4 and CXCR7 activity in human glioblastoma stem-like cells and regulation of the tumor microenvironment.
    Würth R; Bajetto A; Harrison JK; Barbieri F; Florio T
    Front Cell Neurosci; 2014; 8():144. PubMed ID: 24904289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma.
    Sadahiro H; Kang KD; Gibson JT; Minata M; Yu H; Shi J; Chhipa R; Chen Z; Lu S; Simoni Y; Furuta T; Sabit H; Zhang S; Bastola S; Yamaguchi S; Alsheikh H; Komarova S; Wang J; Kim SH; Hambardzumyan D; Lu X; Newell EW; DasGupta B; Nakada M; Lee LJ; Nabors B; Norian LA; Nakano I
    Cancer Res; 2018 Jun; 78(11):3002-3013. PubMed ID: 29531161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perspective of mesenchymal transformation in glioblastoma.
    Kim Y; Varn FS; Park SH; Yoon BW; Park HR; Lee C; Verhaak RGW; Paek SH
    Acta Neuropathol Commun; 2021 Mar; 9(1):50. PubMed ID: 33762019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. EGFRvIII Promotes the Proneural-Mesenchymal Transition of Glioblastoma Multiforme and Reduces Its Sensitivity to Temozolomide by Regulating the NF-κB/ALDH1A3 Axis.
    Shi ZF; Li GZ; Zhai Y; Pan CQ; Wang D; Yu MC; Liu C; Zhang W; Yu XG
    Genes (Basel); 2023 Mar; 14(3):. PubMed ID: 36980923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the mesenchymal subtype in glioblastoma and other cancers via inhibition of diacylglycerol kinase alpha.
    Olmez I; Love S; Xiao A; Manigat L; Randolph P; McKenna BD; Neal BP; Boroda S; Li M; Brenneman B; Abounader R; Floyd D; Lee J; Nakano I; Godlewski J; Bronisz A; Sulman EP; Mayo M; Gioeli D; Weber M; Harris TE; Purow B
    Neuro Oncol; 2018 Jan; 20(2):192-202. PubMed ID: 29048560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.